{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:35:21Z","timestamp":1793414121563,"version":"4.5.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Sleep Med"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s44470-026-00186-5","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:08:07Z","timestamp":1791389287000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Deprescribing benzodiazepine hypnotics and Z-drugs: are DORAs the answer?"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6627-2410","authenticated-orcid":false,"given":"Bhanu Prakash","family":"Kolla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghna P.","family":"Mansukhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"issue":"2","key":"186_CR1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.5664\/jcsm.8986","volume":"17","author":"JD Edinger","year":"2021","unstructured":"Edinger JD, Arnedt JT, Bertisch SM, Carney CE, Harrington JJ, Lichstein KL, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2021;17(2):255\u201362. https:\/\/doi.org\/10.5664\/jcsm.8986.","journal-title":"J Clin Sleep Med"},{"issue":"2","key":"186_CR2","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.clinthera.2025.12.014","volume":"48","author":"Z Yang","year":"2026","unstructured":"Yang Z, Shader RI, Greenblatt DJ. Time trends in prescribing of anxiolytic, sedative, and hypnotic drugs in the United States. Clin Ther. 2026;48(2):196\u2013201. https:\/\/doi.org\/10.1016\/j.clinthera.2025.12.014.","journal-title":"Clin Ther"},{"issue":"12","key":"186_CR3","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1007\/s11606-025-09499-2","volume":"40","author":"E Brunner","year":"2025","unstructured":"Brunner E, Chen CA, Klein T, Maust D, Mazer-Amirshahi M, Mecca M, et al. Joint clinical practice guideline on benzodiazepine tapering: considerations when risks outweigh benefits. J Gen Intern Med. 2025;40(12):2814\u201359. https:\/\/doi.org\/10.1007\/s11606-025-09499-2.","journal-title":"J Gen Intern Med."},{"key":"186_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-081336","volume":"389","author":"D Zeraatkar","year":"2025","unstructured":"Zeraatkar D, Nagraj SK, Ling M, Jassal T, Kirsh S, Lima JP, et al. Comparative effectiveness of interventions to facilitate deprescription of benzodiazepines and other sedative hypnotics: systematic review and meta-analysis. BMJ. 2025;389:e081336. https:\/\/doi.org\/10.1136\/bmj-2024-081336.","journal-title":"BMJ"},{"issue":"1","key":"186_CR5","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s44470-026-00164-x","volume":"22","author":"K Matsui","year":"2026","unstructured":"Matsui K, Sugiura K, Shimura A, Takagi S, Kurihara K, Takaesu Y, et al. Dual orexin receptor antagonist-assisted dose reduction of benzodiazepines and benzodiazepine receptor agonists: a mirror-image analysis of insurance claims data. J Clin Sleep Med. 2026;22(1):163. https:\/\/doi.org\/10.1007\/s44470-026-00164-x.","journal-title":"J Clin Sleep Med."},{"issue":"4","key":"186_CR6","doi-asserted-by":"publisher","first-page":"603","DOI":"10.5664\/jcsm.10946","volume":"20","author":"M Tachibana","year":"2024","unstructured":"Tachibana M, Kanahara N, Oda Y, Hasegawa T, Kimura A, Iyo M. A retrospective clinical practice study comparing the usefulness of dual-orexin receptor antagonists and a melatonin receptor agonist in patients switching from long-term benzodiazepine receptor agonists. J Clin Sleep Med. 2024;20(4):603\u201313. https:\/\/doi.org\/10.5664\/jcsm.10946.","journal-title":"J Clin Sleep Med"},{"issue":"12","key":"186_CR7","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1080\/14656566.2024.2392018","volume":"25","author":"S Tanaka-Mizuno","year":"2024","unstructured":"Tanaka-Mizuno S, Fujimoto K, Mishima K, Sakata Y, Fukasawa T, Mizuno K, et al. Evaluation of prescribing patterns of switching to and add-on lemborexant in patients treated with hypnotic medication: a nationwide claims database study in Japan. Expert Opin Pharmacother. 2024;25(12):1707\u201316. https:\/\/doi.org\/10.1080\/14656566.2024.2392018.","journal-title":"Expert Opin Pharmacother"},{"issue":"10","key":"186_CR8","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.5664\/jcsm.10668","volume":"19","author":"S Horikoshi","year":"2023","unstructured":"Horikoshi S, Miura I, Suzuki Y, Kobayashi Y, Hirata Y, Goto M, et al. Switching to lemborexant for the management of insomnia in mental disorders: the SLIM study. J Clin Sleep Med. 2023;19(10):1753\u20138. https:\/\/doi.org\/10.5664\/jcsm.10668.","journal-title":"J Clin Sleep Med"},{"key":"186_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00016","volume":"5","author":"L de Lecea","year":"2014","unstructured":"de Lecea L, Huerta R. Hypocretin (orexin) regulation of sleep-to-wake transitions. Front Pharmacol. 2014;5:16. https:\/\/doi.org\/10.3389\/fphar.2014.00016.","journal-title":"Front Pharmacol"},{"issue":"5","key":"186_CR10","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S1474-4422(14)70053-5","volume":"13","author":"D Michelson","year":"2014","unstructured":"Michelson D, Snyder E, Paradis E, Chengan-Liu M, Snavely DB, Hutzelmann J, et al. Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2014;13(5):461\u201371. https:\/\/doi.org\/10.1016\/S1474-4422(14)70053-5.","journal-title":"Lancet Neurol"},{"issue":"4","key":"186_CR11","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1007\/s12325-024-02811-2","volume":"41","author":"M Ozone","year":"2024","unstructured":"Ozone M, Hirota S, Ariyoshi Y, Hayashida K, Ikegami A, Habukawa M, et al. Efficacy and safety of transitioning to lemborexant from z-drug, suvorexant, and ramelteon in Japanese insomnia patients: an open-label, multicenter study. Adv Ther. 2024;41(4):1728\u201345. https:\/\/doi.org\/10.1007\/s12325-024-02811-2.","journal-title":"Adv Ther"}],"container-title":["Journal of Clinical Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44470-026-00186-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44470-026-00186-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44470-026-00186-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:08:08Z","timestamp":1791389288000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44470-026-00186-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["186"],"URL":"https:\/\/doi.org\/10.1007\/s44470-026-00186-5","relation":{},"ISSN":["1550-9389","1550-9397"],"issn-type":[{"value":"1550-9389","type":"print"},{"value":"1550-9397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"assertion":[{"value":"14 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"188"}}